BioSupply Trends Quarterly logo
Subscribe
Summer 2015 - Vaccines
  Download Issue
Share

Up Front

Publisher's Corner
Addressing Declining Vaccination Rates
By Patrick M. Schmidt

Features

The Escalating Diabetes Epidemic

Education and Storytelling: An Antidote to Parental Fears About Vaccine Safety

HPV Vaccine: A Dose of Untapped Potential

Myths and Facts: Autism

BioSupply Trends Quarterly Summer 2015 The Vaccine Gap

Mandatory Childhood Vaccines: The Debate

Renal Failure

BioTrends Watch

Washington Report
HHS Contracts with BioCryst to Develop New Ebola Drug
Medicare Rights Center Addresses Enrollment Pitfalls
Pricing and Policies for Biosimilars Are Announced
HHS Launches Digital HIV Educational Tool
HHS Initiative Addresses Opioid-Related Drug Overdose, Death and Dependence
Reimbursement FAQs
Biosimilars Debut in the U.S.
Industry News
New Method to Alleviate Shortage of Plasma Therapies
Grifols Invests in Alkahest to Develop Plasma-Based Products
Scientists Develop Needle-Free Measles Vaccine
Parkinson's Gene Is Linked to Lung Cancer
Novo Nordisk Launches Novoeight for Hemophilia A in the U.S.
FDA Finalizes Guidance Documents on Biosimilars
New Anti-Aging Drug Could Improve Seniors’ Immune Systems
Octapharma USA Launches Co-Pay Program for Wilate
GSK Ebola Shot Is Safe and Provokes an Immune Response
Immune Disorders Genetic Missing Link Found
Pediatrics Academy Updates Measles Recommendations
FDA Accepts BLA for CSL's rIX-FP for Hemophilia B Patients
Novo Nordisk and Janssen Sign an Agreement
Study Shows No Link Between Autism and Measles Vaccine
Shingles Vaccine Developed That Is 97 Percent Effective

BioFocus

Patient Profile
Measles: A Patient's Perspective
By Trudie Mitschang
Disease Profile
Measles Makes a Comeback
By Trudie Mitschang

BioSources

BioResearch
Four-Factor Prothrombin Complex Superior to Plasma for Rapid VKA Reversal
IVIG Monotherapy Mediates Improvement in CLE
BioResources
100% Efficacy in Pivotal Trial of Recombinant von Willebrand Factor Used to Treat Severe von Willebrand Disease